Ausgabe 1/2019
Anti-cancer Immunotherapy: Breakthroughs and Future Strategies
Inhalt (12 Artikel)
Open Access
Review
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
Hans Carl Hasselbalch, Morten Orebo Holmström
Open Access
Review
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
Emmett V. Schmidt
Review
Acquired resistance to cancer immunotherapy
Arianna Draghi, Christopher Aled Chamberlain, Andrew Furness, Marco Donia
Review
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Alexander J. Muller, Mark G. Manfredi, Yousef Zakharia, George C. Prendergast
Review
Principles of adoptive T cell therapy in cancer
Özcan Met, Kasper Mølgaard Jensen, Christopher Aled Chamberlain, Marco Donia, Inge Marie Svane
Review
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
Michelle L. Saetersmoen, Quirin Hammer, Bahram Valamehr, Dan S. Kaufman, Karl-Johan Malmberg
Review
Therapeutic cancer vaccine: building the future from lessons of the past
T. Tran, C. Blanc, C. Granier, A. Saldmann, C. Tanchot, Eric Tartour
Review
Cancer immune therapy for myeloid malignancies: present and future
Morten Orebo Holmström, Hans Carl Hasselbalch
Review
Cancer immune therapy for lymphoid malignancies: recent advances
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Morten Orebo Holmström, Mads Hald Andersen